

Elekta Selects QlikView as Its Enterprise Standard Business Intelligence Solution
RADNOR, Pa.--([ BUSINESS WIRE ])--QlikTech, (NASDAQ:QLIK) a leading business intelligence software company, today announced that Elekta (NASDAQ OMX: EKTA), a leading medical technology company pioneering clinical solutions for treating cancer and brain disorders, has selected QlikView as its global enterprise BI standard. The first roll-out of QlikView applications is taking place now in North America, then to Europe with eventual implementation in 20 countries. With QlikView, the company can easily access and analyze crucial business information, through the BI solutiona™s associative search functionality which helps to generate fast and thorough decisions.
"The employees of Elekta, who have tested QlikView, are all very positive"
aThe employees of Elekta, who have tested QlikView, are all very positive,a says Magnus Kullenberg, BI-manager at Elekta. aEveryone using QlikView think ita™s fantastic. The applications are extraordinarily user friendly. It is very easy for users to extract the data needed and even if it looks simplistic, ita™s a very complex analysis underneath. There are many potential ways to use QlikView a" our business areas are constantly changing and now we have the possibility to speedily build new applications when we need them to fit our ever changing needs.a
Initially, Elekta is focusing on gaining total visibility into business systems using data from the ERP system Movex. The applications give better control over business processes and, therefore enable faster decisions. The software will primarily be used in financials, customer service and project management. The company will integrate CRM-applications with the financial system to enable analysis on data from both platforms.
aWe are very proud that the world leader in radio surgery and radiation therapy has chosen to use another leading Swedish innovation, QlikView, as their decision support,a says Les Bonney, Executive Vice President, Global Sales, QlikTech. aQlikView can create detailed analysis of enterprise-wide corporate operations to transform their data into useful, actionable information.a
About Elekta
Elekta is a medical technology company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radio surgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group. Elekta employs approximately 2,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Stock Exchange Nasdaq/OMX under the ticker EKTA.
About QlikTech
QlikTecha™s powerful, accessible business intelligence solution enables organizations to make better and faster decisions. Its QlikView product delivers enterprise-class analytics and search with the simplicity and ease of use of office productivity software. The in-memory associative search technology it pioneered makes calculations in real-time enabling business professionals to gain insight through intuitive data exploration. Unlike traditional business intelligence products, QlikView can deliver value in days or weeks rather than months, years, or not at all. It can be deployed on premise, in the cloud, or on a laptop or mobile devicea"from a single user to large global enterprises. QlikTech (NASDAQ: [ QLIK ]) is headquartered in Radnor, Pennsylvania, with offices around the world and more than 16,000 customers in over 100 countries worldwide.